Pdf Subanesthetic Ketamine Infusions For The Treatment Of Children These data suggest that subanesthetic ketamine infusion is feasible in an outpatient setting and may benefit children and adolescents with chronic pain. further, patients with crps, pots, and a history of trauma related chronic pain are more likely to benefit from this therapeutic modality. Over a 15 month period, 63 children and adolescents (median age 15, interquartile range 12–17 years) with chronic pain received 277 ketamine infusions. intravenous administration of subanesthetic doses of ketamine to children and adolescents on an outpatient basis was safe and not associated with psychotropic effects or hemodynamic perturbations.
Subanesthetic Ketamine Infusions For Chronic Pain In Children And Background chronic pain is common in children and adolescents and is often associated with severe functional disability and mood disorders. the pharmacological treatment of chronic pain in children and adolescents can be challenging, ineffective, and is mostly based on expert opinions and consensus. ketamine, an n methyl d aspartate receptor antagonist, has been used as an adjuvant for. Chronic pain, defined as pain lasting for more than 3 months, is common in children and adolescents and its prevalence varies according to pain location and associated primary disease [ 1 – 4 ]. clinicians treating children and adolescents with …. Effect of ketamine infusions on pain scores (numeric rating scale) in children and adolescents with chronic pain. the box plots show the data’s median and interquartile range and the whiskers. The median duration of the infusions was 63.8 hours and 0.2 mg kg hour for the highest dose. the primary indication for ketamine was chronic pain exacerbation (83.3%). despite similar opioid consumption, there was a significant reduction in mean verbal pain scores before (8.9 ± 1.9, p < .001) and after ketamine (6.5 ± 2.7, p < .001) use.
Ketamine Infusion For Chronic Pain Protocol Effect of ketamine infusions on pain scores (numeric rating scale) in children and adolescents with chronic pain. the box plots show the data’s median and interquartile range and the whiskers. The median duration of the infusions was 63.8 hours and 0.2 mg kg hour for the highest dose. the primary indication for ketamine was chronic pain exacerbation (83.3%). despite similar opioid consumption, there was a significant reduction in mean verbal pain scores before (8.9 ± 1.9, p < .001) and after ketamine (6.5 ± 2.7, p < .001) use. In this systematic review, 14 studies met the inclusion criteria and were reviewed. in these studies, the dosage of ketamine infusion used ranged from 0.15 mg kg to 7 mg kg with the primary indication being the treatment of crps. in 13 of the studies, ketamine infusion resulted in a decrease in pain scores and relief of symptoms. Results: the study cohort included 230 different patients who during 360 separate hospital admissions received subanesthetic ketamine infusions for pain management. overall, ketamine infusions were associated with significant reductions in mean pain scores from baseline (mean pain scores 6.64 [95% ci: 6.38 6.90]) to those recorded on the day.
Comments are closed.